These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 6411843)

  • 1. The inactivation of hemostatic factors by hematin.
    Green D; Reynolds N; Klein J; Kohl H; Ts'ao CH
    J Lab Clin Med; 1983 Sep; 102(3):361-9. PubMed ID: 6411843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of hepes buffer on clotting tests, assay of factors V and VIII and on the hydrolysis of esters by thrombin and thrombokinase.
    Roberts PS; Hughes HN; Fleming PB
    Thromb Haemost; 1976 Feb; 35(1):202-10. PubMed ID: 989187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentration effects of platelets, fibrinogen and thrombin on platelet aggregation and fibrin clotting.
    Chao FC; Tullis JL; Kenney DM; Conneely GS; Doyle JR
    Thromb Diath Haemorrh; 1974 Sep; 32(1):216-31. PubMed ID: 4454041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor.
    von dem Borne PA; Cox LM; Bouma BN
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):251-7. PubMed ID: 16651866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematin: effects on hemostasis.
    Green D; Ts'ao CH
    J Lab Clin Med; 1990 Feb; 115(2):144-7. PubMed ID: 2405084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation.
    Gresele P; Momi S; Berrettini M; Nenci GG; Schwarz HP; Semeraro N; Colucci M
    J Clin Invest; 1998 Feb; 101(3):667-76. PubMed ID: 9449701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of concomitant thrombin-mediated fibrin formation enhances clot lysis in whole blood.
    Haskel EJ; Eisenberg PR; Abendschein DR
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):7-13. PubMed ID: 8457655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematin-derived anticoagulant. Generation in vitro and in vivo.
    Jones RL
    J Exp Med; 1986 Mar; 163(3):724-39. PubMed ID: 3950544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.
    Guimarães AH; Rijken DC
    Thromb Haemost; 2004 Mar; 91(3):473-9. PubMed ID: 14983222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperacute renal allograft rejection in the primate. Intrarenal effects of heparin and associated net release of factor VIII activity and kallikrein activation.
    Busch GJ; Kobayashi K; Hollenberg NK; Birtch AG; Colman RW
    Am J Pathol; 1975 Jul; 80(1):1-20. PubMed ID: 1098475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of thrombin on human factor VIII. Cleavage of the factor VIII procoagulant protein during activation.
    Hoyer LW; Trabold NC
    J Lab Clin Med; 1981 Jan; 97(1):50-64. PubMed ID: 6778941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmin-induced procoagulant effects in the blood coagulation: a crucial role of coagulation factors V and VIII.
    Ogiwara K; Nogami K; Nishiya K; Shima M
    Blood Coagul Fibrinolysis; 2010 Sep; 21(6):568-76. PubMed ID: 20625277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relative kinetics of clotting and lysis provide a biochemical rationale for the correlation between elevated fibrinogen and cardiovascular disease.
    Kim PY; Stewart RJ; Lipson SM; Nesheim ME
    J Thromb Haemost; 2007 Jun; 5(6):1250-6. PubMed ID: 17266698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin generation and clot formation in methylene blue-treated plasma and cryoprecipitate.
    Cardigan R; Philpot K; Cookson P; Luddington R
    Transfusion; 2009 Apr; 49(4):696-703. PubMed ID: 19170989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulant albumin fragments that bind to fibrinogen/fibrin: possible implications.
    Galanakis DK
    Semin Thromb Hemost; 1992 Jan; 18(1):44-52. PubMed ID: 1574716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of fibrinogen and fibrin on thrombin generation--evidence for feedback activation of the clotting system by clot bound thrombin.
    Kumar R; Béguin S; Hemker HC
    Thromb Haemost; 1994 Nov; 72(5):713-21. PubMed ID: 7900079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: an update.
    Despotis GJ; Joist JH
    J Cardiothorac Vasc Anesth; 1999 Aug; 13(4 Suppl 1):18-29; discussion 36-7. PubMed ID: 10468245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinogen and its derivatives: cofactors in the intrinsic generation of thrombin.
    Triantaphyllopoulos DC; Ryan LT
    Thromb Haemost; 1976 Apr; 35(2):305-13. PubMed ID: 989630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.